AB

AAVantgarde Bio at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

AAVantgarde Bio at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
AB
AAVantgarde Bio
Milan, Italy
Biotech
Develops dual-AAV gene therapies for inherited retinal diseases such as Usher syndrome and Stargardt disease.
Panel
Wed Nov 11
10:00–10:45
Envisioning the future of ophthalmology
What new data show about treatments for retinal disease, glaucoma and other eye conditions, and where investors see the most promise.
with Micro CRISPR, Boehringer Ingelheim, Inveready +1 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AAVantgarde Bio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction